News | Congenital Heart

May 1, 2021 - An analysis of a new international registry reveals benefits of using a longer covered stent for ...

Home May 01, 2021
Home
Videos | Structural Heart

Ashwin Nathan M.D., a cardiology fellow at the Hospital of the University of Pennsylvania, presented a late-breaking ...

Home April 30, 2021
Home
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
Feature | Structural Heart | Dave Fornell, Editor

April 30, 2021 — New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve ...

Home April 30, 2021
Home
The two FDA-clear transcatheter aortic valve replacement (TAVR) valves on the market, the Edwards Lifesciences Sapien 3 (left) and the Medtronic CoreValve (right).
Feature | Structural Heart

April 30, 2021 – An analysis of growth patterns in transcatheter aortic valve replacement (TAVR) programs across United ...

Home April 30, 2021
Home
News | Cath Lab

April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American ...

Home April 29, 2021
Home
The Abiomed Impella percutaneous heart pump was shown in the NCSI study to greatly improve survival of acute myocardial infarction with cardiogenic shock (AMICS), raising survival from 50 percent to 71 percent. Ambulance image from Getty Images.
Feature | Cardiogenic Shock | By Dave Fornell, Editor

April 29, 2021 — The results of a large, national heart attack study show that patients with cardiogenic shock survived ...

Home April 29, 2021
Home
News | Antiplatelet and Anticoagulation Therapies

April 28, 2021 — An analysis of the prospective Chinese Fuwai PCI Registry, confirms long-term, dual-antiplatelet ...

Home April 28, 2021
Home
News | Radial Access | Dave Fornell, Editor

April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to ...

Home April 28, 2021
Home
Videos | Cardiogenic Shock

William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit ...

Home April 28, 2021
Home
News | Cath Lab

April 28, 2021 – Results from a retrospective observational study, presented today at Society for Cardiovascular ...

Home April 28, 2021
Home
News | Cath Lab

April 28, 2021 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus ...

Home April 28, 2021
Home
News | EP Lab

April 26, 2021 — Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for ...

Home April 26, 2021
Home
Sponsored Content | Webinar | Structural Heart

This on-demand webinar teaches viewers how new multi-planar imaging techniques such as Cardiac MultiVue and TrueVue make ...

Home April 26, 2021
Home
News | Heart Failure

April 26, 2021 – Cardiovascular diseases are the leading cause of death in the United States. Heart failure ...

Home April 26, 2021
Home
Transesophageal echo (TEE) being used to guide the deployment of a MitraClip device during a structural heart procedure at the University of Colorado Hospital. The center has performed more than 200 MitraClip mitral valve repairs over the past decade. Photo by Dave Fornell
Feature | Structural Heart

The resounding success of transcatheter aortic valve replacement (TAVR) has led the creation of hundreds of structural ...

Home April 22, 2021
Home
Subscribe Now